The global chronic heart failure therapeutics market is witnessing a period of substantial growth. This trend can be attributed to the increasing prevalence of chronic heart failure globally, coupled with advancements in treatment approaches. The sector is characterized by a diverse range of treatments, addressing different aspects of the disease.